Cannabix Technologies Evaluates Expansion of Breath-Based Biomarker Platform
Cannabix says it is evaluating use of its Breath Collection Unit technology in the breath-based health and biomarker market.
Related stories
Foshan Haitian Reports Quarterly Net Profit of RMB1.19 Billion
M impact | EQUITY | Oct 29, 2026, 09:33 AM UTC
Indonesia Central Bank Chief Calls MSCI Warning a 'Short-Term Shock'
L impact | EQUITY | Oct 29, 2026, 09:33 AM UTC
Chin Teck Plantations Reports Q4 Profit of RGT 36.4 Million
M impact | EQUITY | Oct 29, 2026, 09:32 AM UTC
Chin Teck Plantations reports Q4 revenue of RGT 56.4 million
M impact | EQUITY | Oct 29, 2026, 09:32 AM UTC
Jordan International Insurance Reports Q3 Revenue of 506,003 Dinars
M impact | EQUITY | Oct 29, 2026, 09:32 AM UTC
Chin Teck Plantations Reports Fourth-Quarter 2026 Earnings
For the quarter ended Aug. 31, revenue was MYR 56,367,000 versus MYR 96,649,000 in 2025. Pretax profit was MYR 43,166,000; the prior-year figure is truncated in the source.
M impact | EQUITY | Oct 29, 2026, 09:32 AM UTC